Stock Price Newsletter – September 16, 2019

Tiziana Life Sciences (TLSA) Announces FDA Approval to Initiate Phase I Clinical…

Tiziana Life Sciences (TLSA) Announces FDA Approval to Initiate Phase I Clinical Trial with Orally Administered Foralumab in Healthy Volunteers

A breakthrough approach for treatment of autoimmune and inflammatory diseases London, 16…

Stock Price Newsletter – September 13, 2019

In Case You Missed It: PharmaCyte Biotech (PMCB) Releases Results of Shareholder…

Tesla (TSLA) Stock Price Makes Big Move; Time To Buy Or Sell?

Electric car manufacturing giant Tesla Inc (TSLA Stock Report) has had a…

GT Biopharma (GTBP) Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike™ Phase i/ii Clinical Trial

TAMPA, Florida, Sept. 12, 2019 /PRNewswire/ — GT Biopharma, Inc. (GTBP) (GTBP.PA) an immuno-oncology…

PharmaCyte Biotech (PMCB) Releases Results of Shareholder Meeting and Provides Information on Upcoming Shareholder Update Call

LAGUNA HILLS, Calif.–(BUSINESS WIRE)– PharmaCyte Biotech, Inc. (PMCB), a biotechnology company focused on…

Stock Price Thursday Morning Update – September 12, 2019

Liberty Defense (LDDFF) (SCAN) Signs Maryland Stadium Authority, Camden Yards Sports Complex…

Liberty Defense (LDDFF) (SCAN) Signs Maryland Stadium Authority, Camden Yards Sports Complex

BALTIMORE and VANCOUVER , Sept. 12, 2019 /CNW/ – Liberty Defense Holdings…

Is Facebook (FB) Stock Price Signaling Buy Or Sell?

Facebook stock price (FB Stock Report) has grown at a breakneck pace.…

Stock Price Wednesday Morning Newsletter – September 11, 2019

Markets may be mixed but for certain sectors, momentum may be set…